Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: A prospective, multicenter study of 91 episodes

Clinical Infectious Diseases

Volumn 22, Issue 3, 1996, Pages 508-512

  Muder, Robert R ^a   Harris, Ann P ^b   Muller, Sharon ^b   Edmond, Michael ^b   Chow, Joseph W ^b   Papadakis, Konstantinos ^b   Wagener, Marilyn W ^b   Bodey, Gerald P ^b   Steckelberg, James M ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE;

ACTIVE IMMUNIZATION; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; CANCER PATIENT; HUMAN; IMMUNE STATUS; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MAJOR CLINICAL STUDY; NEUTROPENIA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STENOTROPHOMONAS MALTOPHILIA;

EID: 0029782406     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.3.508     Document Type: Article

References (18)

1. Gilardi GL. Pseudomonas maltophilia infections in man. Am J Clin Pathol 1969;51:58-61.
2. Zuravleff JJ, Yu VL. Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature. Rev Infect Dis 1982;4:1236-46.
3. Muder RR, Yu VL, Dummer JS, Vinson C, Lumish RM. Infections caused by Pseudomonas maltophilia: expanding clinical spectrum. Arch Intern Med 1987;147:1672-4.
4. Marshall WF, Keating MR, Anhalt JP, Steckelberg JM. Xanthomonas maltophilia: an emerging nosocomial pathogen. Mayo Clin Proc 1989;64:1097-I04.
5. Khardori N, Elting L, Wong E, Schable B, Bodey GP. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis 1990;12:997-1003.
6. Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 1990;69:296-306.
7. Felegie TP, Yu VL, Rumans LW, Yee RB. Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrob Agents Chemother 1979;16:833-7.
8. Morrison AJ, Hoffmann KK., Wenzel RP. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J Clin Microbiol 1986;24:52-5.
9. Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989;87:540-6.
10. Korvick JA, Bryan CS, Farber B, et al. A prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother 1992;36:2639-44.
11. Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585-90.
12. Hugh R, Ryschenkow E. Pseudomonas maltophilia, an Alcaligenes-like species. J Gen Microbiol 1961;26:123-32.
13. Swings J, De Vos P, Van den Mooter M, De Ley J. Transfer of Pseudomonas maltophilia Hugh 1981 to the genus Xanthomonas as Xanthomonas maltophilia (Hugh 1981) comb. nov. Int J Syst Bacteriol 1983;33:409-13.
14. Palleroni NJ, Bradbury JF. Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int J Syst Bacteriol 1993;43:606-9.
15. Fisher MC, Long SS, Roberts EM, Dunn JM, Balsara RK. Pseudomonas maltophilia bacteremia in children undergoing open heart surgery. JAMA 1981;241:1571-4.
16. Aoun M, Van der Auwera P, Devleeshouwer C, et al. Bacteraemia caused by non-aeruginosa Pseudomonas species in a cancer centre. J Hosp Infect 1992;22:307-16.
17. Gilardi GL. Infrequently encountered Pseudomonas species causing infection in humans. Ann Intern Med 1972;77:211-5.
18. Noskin GA, Grohmann SM. Xanthomonas maltophilia bactermia: an analysis of factors influencing outcome. Infect Dis Clin Pract 1992;1:230-6.